Diabetes 50:83-90, 2001
© 2001 by the American Diabetes Association, Inc.
Decreased In Situ Insulin Receptor Dephosphorylation in Hyperglycemia-Induced Insulin Resistance in Rat Adipocytes
Shangguo Tang,
Hoang Le-Tien,
Barry J. Goldstein,
Phillip Shin,
Robert Lai, and
I. George Fantus
From the Department of Medicine (I.G.F.), Mount Sinai Hospital and the
University Health Network; the Department of Physiology (P.S., I.G.F.) and
Banting and Best Diabetes Centre (S.T., H.L.-T., P.S., R.L., I.G.F.),
University of Toronto, Toronto, Ontario, Canada; and the Department of
Medicine and the Dorrance H. Hamilton Research Laboratories (B.J.G.),
Jefferson Medical College, Philadelphia, Pennsylvania.
Address correspondence and reprint requests to Dr. I.G. Fantus, Department of
Medicine, Mount Sinai Hospital, 600 University Ave., Rm. 780, Toronto, ON M5G
1X5, Canada. E-mail:
fantus{at}mshri.on.ca
.
The regulation of insulin receptor (IR) tyrosine (tyr) phosphorylation is a
key step in the control of insulin signaling. Augmented IR tyr
dephosphorylation by protein tyrosine phosphatases (PTPs) may contribute to
insulin resistance. To investigate this possibility in hyperglycemia-induced
insulin resistance, primary cultured rat adipocytes were rendered
insulin-resistant by chronic exposure (18 h) to 15 mmol/l glucose combined
with 10-7 mol/l insulin. Insulin-resistant adipocytes showed a
decrease in insulin sensitivity and a maximum response of 2-deoxyglucose
uptake, which was associated with a decrease in maximum insulin-stimulated IR
tyr phosphorylation in situ. To assess tyr dephosphorylation, IRs of
insulin-stimulated permeabilized adipocytes were labeled with
[ -32P]ATP and chased for 2 min with unlabeled ATP in the
presence of EDTA. In a nonradioactive protocol, insulin-stimulated adipocytes
were permeabilized and exposed to EDTA and erbstatin for 2 min, and IRs were
immunoblotted with anti-phosphotyrosine (pY) antibodies. Both methods showed a
similar diminished extent of IR tyr dephosphorylation in resistant cells.
Immunoblotting of four candidate IR-PTPs demonstrated no change in PTP1B or
the SH2 domain containing phosphatase-2 (SHP-2), whereas a significant
decrease in leukocyte antigen-related phosphatase (LAR) (51 ± 3% of
control) and an increase in PTP- (165 ± 16%) were found.
Activity of immunoprecipitated PTPs toward a triple tyr phosphorylated IR
peptide revealed a correlation with protein content for PTP1B, SHP-2, and LAR
but a decrease in apparent specific activity of PTP- . The data indicate
that decreased IR tyr phosphorylation in hyperglycemia-induced insulin
resistance is not due to enhanced dephosphorylation. The diminished IR tyr
dephosphorylation observed in this model is associated with decreased LAR
protein content and activity.

CiteULike Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. Ordonez, M. Moreno, A. Alonso, R. Fernandez, F. Diaz, and C. Gonzalez
Neuroendocrinology/Endocrinology: Insulin sensitivity in streptozotocin-induced diabetic rats treated with different doses of 17{beta}-oestradiol or progesterone
Exp Physiol,
January 1, 2007;
92(1):
241 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. M. Beard, H. Lu, K. Ho, and I. G. Fantus
Bradykinin Augments Insulin-Stimulated Glucose Transport in Rat Adipocytes via Endothelial Nitric Oxide Synthase-Mediated Inhibition of Jun NH2-Terminal Kinase.
Diabetes,
October 1, 2006;
55(10):
2678 - 2687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Lin, A. H. Berg, P. Iyengar, T. K. T. Lam, A. Giacca, T. P. Combs, M. W. Rajala, X. Du, B. Rollman, W. Li, et al.
The Hyperglycemia-induced Inflammatory Response in Adipocytes: THE ROLE OF REACTIVE OXYGEN SPECIES
J. Biol. Chem.,
February 11, 2005;
280(6):
4617 - 4626.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Lu, D. Ennis, R. Lai, E. Bogdanovic, R. Nikolov, L. Salamon, C. Fantus, H. Le-Tien, and I. G. Fantus
Enhanced Sensitivity of Insulin-resistant Adipocytes to Vanadate Is Associated with Oxidative Stress and Decreased Reduction of Vanadate (+5) to Vanadyl (+4)
J. Biol. Chem.,
September 14, 2001;
276(38):
35589 - 35598.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Diabetes Association.
|
|
| |
|